LY3023414 and Prexasertib in Metastatic Triple-negative Breast Cancer
Clinical trial NCT04032080 · COMPLETED
Trial details
- NCT number
- NCT04032080
- Sponsor
- Baylor Research Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-05
- Primary completion
- 2022-06-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.